NASDAQ:BLUE (Bluebird Bio)

About BLUE

Bluebird Bio is a development-stage biotechnology company focused on gene therapy, gene editing, and cancer immunotherapy.
  • Bluebird Bio (NASDAQ: BLUE) Latest News

    No posts found.